DOI: http://dx.doi.org/10.18203/2349-3933.ijam20192267

Comparison of Model for End Stage Liver Disease-Na score and Model for End Stage Liver Disease score in predicting in-hospital mortality in patients with end stage liver disease: an observational study

Tirthankar Mukherjee, Kamalesh Tagadur Nataraju, B. M. Rakesh, Soumya Dattanagowda Dandothi

Abstract


Background: Model for End-stage Liver Disease (MELD) score was originally developed to predict mortality after trans jugular intrahepatic portosystemic shunt. Hyponatremia is the most common electrolyte abnormality in End Stage Liver Disease (ESLD). Incorporating serum sodium into MELD score increases its predictive accuracy.

Methods: This is an observational study conducted on 50 patients of ESLD admitted from October 2012 to September 2014. Study population was divided into survivor and non-survivor groups. MELD score and Model for End Stage Liver Disease-Na (MELD-Na) score was calculated and compared between the groups.

Results: Out of 50 participants, 20 (40%) died in the hospital due to cirrhosis related complications.  The average age was 44.7±12.040 years in the survivor group and 54.1±9.910 years in the non-survivor group. The mean MELD score and MELD-Na score was found to be higher in non-survivors group (28.5 and 30.5) compared to survivors group (22.03 and 25.67) which was statistically very significant. Majority of the patients in survivor group had MELD score between 10-19 (43.3%) and 30-39 (36.7%). In the non-survivor group majority of patients had score of more than 20 (80%). MELD-Na score has better sensitivity (90%) compared to MELD score (80%) at a cut off value above 22. However, MELD score has better specificity (60%) compared to MELD-Na score (43.3%) at the same cut off value.

Conclusions: MELD-Na score was higher in non-survivor group with good predictability for in-hospital mortality and there was good correlation between both the scores in terms of degree of agreement and MELD-Na score was more sensitive compared to MELD score.


Keywords


Cirrhosis, MELD, MELD-Na

Full Text:

PDF

References


Perri GA. Complications of end-stage liver disease. Can Fam Physic. 2016;62(1):44-50.

Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep. 2008;56(10):1-20.

Schuppan, D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371(9615):838-51.

Infante-Rivard C, Esnaola S, Villeneuve JP. Clinical and statistical validity of conventional prognostic factors in predicting short-term survival among cirrhotics. Hepatol. 1987;7:660-4.

Malinchoc, M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatol. 2000;31:864-71.

Kamath P, Wiesner R, Malinchoc M, Kremers W, Therneau T, Kosberg C, et al. A model to predict survival in patients with end-stage liver disease. Hepatol. 2001;33:464-70

Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterol. 2003;124:91-6.

Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system (moving toward evidence-based transplantation policy). Liver Transpl. 2002;8:851-8.

Porcel A, Diaz F, Rendon P, Macias M, Martin-Herrera L, Giron-Gonzalez JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med. 2002;162:323-8.

Arroyo V, Colmenero J. Ascites and hepatorenal syndrome in cirrhosis (pathophysiological basis of therapy and current management). J Hepatol. 2003;38:S69-89.

Gines, A, Escorsell A, Gines P, Salo J, Jimenez W, Inglada L, Navasa M, et al. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterol. 1993;105:229-36.

Cosby RL, Yee B, Schrier RW. New classification with prognostic value in cirrhotic patients. Miner Electrolyte Metab. 1989;15:261.

Borroni G, Maggi A, Sangiovanni A, Cazzaniga M, Salerno F. Clinical relevance of hyponatraemia for the hospital outcome of cirrhotic patients. Dig Liver Dis. 2000;32:605-10.

Fernandez-Esparrach G, Sanchez-Fueyo A, Gines P, Uriz J, Quinto L, Ventura PJ, et al. A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol. 2001;34:46-52.

Shear L, Kleinerman J, Gabuzda GJ. Renal failure in patients with cirrhosis of the liver. I. Clinical and pathologic characteristics. Am J Med. 1965;39:184-98.

Llach J, Gines P, Arroyo V, Rimola A, Tito L, Badalamenti S, et al. Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterol. 1988;94:482-7.

Earley L, Sanders C. The effect of changing serum osmolality on the release of antidiuretic hormone in certain patients with decompensated cirrhosis of the liver and low osmolality. J Clin Invest. 1959;38:545-0.

Arroyo V, Rodes J, Gutierrez-Lizarraga MA, Revert L. Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis. 1976; 21:249-56.

Huo TI, Wang YW, Yang YY, Lin HC, Lee PC, Hou MC, et al. Model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor and its correlation with portal pressure in patients with liver cirrhosis. Liver Int. 2007;27(4):498-506.

Heuman DM, Abou‐Assi SG, Habib A, Williams LM, Stravitz RT, Sanyal AJ, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death. Hepatol. 2004;40(4):802-10.

Cholongitas E, Marelli L, Kerry A, Senzolo M, Goodlier DW, Nair D, et al. Different methods of creatinine measurement significantly affect MELD scores. Liver Trans. 2007;13:523-9.

Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterol. 2006;130:1652-0.

Heuman DM, Mihas AA, Habib A, Gilles HS, Stravitz RT, Sanyal AJ, et al. MELD-XI: a rational approach to ‘‘sickest first’’ liver transplantation in cirrhotic patients requiring anticoagulant therapy. Liver Transp. 2007;13:30-7.

Martin EF, O’Brien C. Update on MELD and organ allocation. Clin Liver Dis. 2014;5(4):105-7.

Serste T, Gustot T, Rautou PE. Severe hyponatremia is a better predictor of mortality than MELD-Na in patients with cirrhosis and refractory ascites. J Hepatol. 2012;57(2):274-80.